These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 15650453)

  • 1. 18F-FDG PET early after radiotherapy in lymphoma patients.
    Castellucci P; Zinzani P; Nanni C; Farsad M; Moretti A; Alinari L; Battista G; Pettinato C; Marengo M; Boschi S; Canini R; Baccarani M; Monetti N; Fanti S
    Cancer Biother Radiopharm; 2004 Oct; 19(5):606-12. PubMed ID: 15650453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET in malignant lymphoma: significance of positive findings.
    Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma.
    Riad R; Omar W; Sidhom I; Zamzam M; Zaky I; Hafez M; Abdel-Dayem HM
    Nucl Med Commun; 2010 Mar; 31(3):232-8. PubMed ID: 20032800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
    J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
    Qiu L; Chen Y; Wu J
    Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 18F-FDG positron emission tomography following allogeneic transplantation to guide adoptive immunotherapy with donor lymphocyte infusions.
    Hart DP; Avivi I; Thomson KJ; Peggs KS; Morris EC; Goldstone AH; Linch DC; Ell PJ; Bomanji JB; Mackinnon S
    Br J Haematol; 2005 Mar; 128(6):824-9. PubMed ID: 15755287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
    Castellucci P; Nanni C; Farsad M; Alinari L; Zinzani P; Stefoni V; Battista G; Valentini D; Pettinato C; Marengo M; Boschi S; Canini R; Baccarani M; Monetti N; Franchi R; Rampin L; Fanti S; Rubello D
    Nucl Med Commun; 2005 Aug; 26(8):689-94. PubMed ID: 16000986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET and PET/CT in Burkitt's lymphoma.
    Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA
    Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: Systematic review and meta-analysis.
    Adams HJA; Kwee TC
    Eur J Radiol; 2016 Nov; 85(11):1963-1970. PubMed ID: 27776647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
    Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
    Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 18F-FDG positron emission tomography and computed tomography in patients with colorectal carcinoma and lymphoma: our initial clinical experience.
    Coha B; Radmilović K; Gardasanić J; Daković M; Stefanić M; Latić A; Mitrecić D
    Acta Clin Croat; 2009 Mar; 48(1):35-9. PubMed ID: 19623870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging for response assessment in lymphoma: potential and limitations.
    Schöder H; Moskowitz C
    Radiol Clin North Am; 2008 Mar; 46(2):225-41, viii. PubMed ID: 18619378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
    Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM
    Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous bone marrow uptake on interim 18F-fluorodeoxyglucose positron emission tomography for lymphoma mimicking disease progression: a case report.
    Cherk MH; Patil S; Beech P; Kalff V
    J Med Case Rep; 2014 Nov; 8():362. PubMed ID: 25377897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
    Iino M; Iizuka C
    Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma.
    Asakura H; Togami T; Mitani M; Takashima H; Yokoe K; Yamamoto Y; Nishiyama Y; Monden T; Toyama Y; Ohkawa M
    Ann Nucl Med; 2005 Dec; 19(8):725-8. PubMed ID: 16445000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy].
    Lorenzen J; de Wit M; Buchert R; Igel B; Bohuslavizki KH
    Nuklearmedizin; 1999; 38(8):333-6. PubMed ID: 10615668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas.
    Mikhaeel NG
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33 Suppl 1():22-6. PubMed ID: 16779556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of molecular imaging and radioimmunotherapy in lymphoma.
    Iagaru A; Goris ML; Gambhir SS
    Radiol Clin North Am; 2008 Mar; 46(2):243-52, viii. PubMed ID: 18619379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.